These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 19420084)

  • 21. Inhibition of NF-κB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival.
    DeDiego ML; Nieto-Torres JL; Regla-Nava JA; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodriguez C; Perlman S; Enjuanes L
    J Virol; 2014 Jan; 88(2):913-24. PubMed ID: 24198408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice.
    Channappanavar R; Fehr AR; Vijay R; Mack M; Zhao J; Meyerholz DK; Perlman S
    Cell Host Microbe; 2016 Feb; 19(2):181-93. PubMed ID: 26867177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.
    Zhang H; Wang G; Li J; Nie Y; Shi X; Lian G; Wang W; Yin X; Zhao Y; Qu X; Ding M; Deng H
    J Virol; 2004 Jul; 78(13):6938-45. PubMed ID: 15194770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury.
    Gralinski LE; Bankhead A; Jeng S; Menachery VD; Proll S; Belisle SE; Matzke M; Webb-Robertson BJ; Luna ML; Shukla AK; Ferris MT; Bolles M; Chang J; Aicher L; Waters KM; Smith RD; Metz TO; Law GL; Katze MG; McWeeney S; Baric RS
    mBio; 2013 Aug; 4(4):. PubMed ID: 23919993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge.
    Bolles M; Deming D; Long K; Agnihothram S; Whitmore A; Ferris M; Funkhouser W; Gralinski L; Totura A; Heise M; Baric RS
    J Virol; 2011 Dec; 85(23):12201-15. PubMed ID: 21937658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV.
    Yasui F; Kai C; Kitabatake M; Inoue S; Yoneda M; Yokochi S; Kase R; Sekiguchi S; Morita K; Hishima T; Suzuki H; Karamatsu K; Yasutomi Y; Shida H; Kidokoro M; Mizuno K; Matsushima K; Kohara M
    J Immunol; 2008 Nov; 181(9):6337-48. PubMed ID: 18941225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro.
    Wang X; Xu W; Tong D; Ni J; Gao H; Wang Y; Chu Y; Li P; Yang X; Xiong S
    Immunol Lett; 2008 Aug; 119(1-2):71-7. PubMed ID: 18533276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species.
    Smits SL; van den Brand JM; de Lang A; Leijten LM; van Ijcken WF; van Amerongen G; Osterhaus AD; Andeweg AC; Haagmans BL
    J Virol; 2011 May; 85(9):4234-45. PubMed ID: 21325418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice.
    Hu H; Lu X; Tao L; Bai B; Zhang Z; Chen Y; Zheng F; Chen J; Chen Z; Wang H
    Clin Vaccine Immunol; 2007 Jul; 14(7):894-901. PubMed ID: 17494640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein.
    Fett C; DeDiego ML; Regla-Nava JA; Enjuanes L; Perlman S
    J Virol; 2013 Jun; 87(12):6551-9. PubMed ID: 23576515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections.
    Li F
    J Virol; 2008 Jul; 82(14):6984-91. PubMed ID: 18448527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronavirus virulence genes with main focus on SARS-CoV envelope gene.
    DeDiego ML; Nieto-Torres JL; Jimenez-Guardeño JM; Regla-Nava JA; Castaño-Rodriguez C; Fernandez-Delgado R; Usera F; Enjuanes L
    Virus Res; 2014 Dec; 194():124-37. PubMed ID: 25093995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice.
    Greenough TC; Babcock GJ; Roberts A; Hernandez HJ; Thomas WD; Coccia JA; Graziano RF; Srinivasan M; Lowy I; Finberg RW; Subbarao K; Vogel L; Somasundaran M; Luzuriaga K; Sullivan JL; Ambrosino DM
    J Infect Dis; 2005 Feb; 191(4):507-14. PubMed ID: 15655773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of severe acute respiratory syndrome.
    Lau YL; Peiris JS
    Curr Opin Immunol; 2005 Aug; 17(4):404-10. PubMed ID: 15950449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection.
    Fehr AR; Channappanavar R; Jankevicius G; Fett C; Zhao J; Athmer J; Meyerholz DK; Ahel I; Perlman S
    mBio; 2016 Dec; 7(6):. PubMed ID: 27965448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratory syndrome coronavirus spike-ACE2 signaling pathway.
    Chen IY; Chang SC; Wu HY; Yu TC; Wei WC; Lin S; Chien CL; Chang MF
    J Virol; 2010 Aug; 84(15):7703-12. PubMed ID: 20484496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.
    Frieman MB; Chen J; Morrison TE; Whitmore A; Funkhouser W; Ward JM; Lamirande EW; Roberts A; Heise M; Subbarao K; Baric RS
    PLoS Pathog; 2010 Apr; 6(4):e1000849. PubMed ID: 20386712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
    ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
    PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain.
    Shim BS; Stadler K; Nguyen HH; Yun CH; Kim DW; Chang J; Czerkinsky C; Song MK
    Virol J; 2012 Sep; 9():215. PubMed ID: 22995185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS.
    Callendret B; Lorin V; Charneau P; Marianneau P; Contamin H; Betton JM; van der Werf S; Escriou N
    Virology; 2007 Jul; 363(2):288-302. PubMed ID: 17331558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.